Zvexneo

N/A

Report date: 2026/05/12 09:09:10

Base Information

Drug NameZvexneo
Drug Alias NameGRANITElutadenovec autogeneGRT-C901/GRT-R902GRANITE-001
ClassificationVaccines > Development/production technology > Nucleic acid vaccine > RNA vaccine > mRNA vaccine > personalized mRNA cancer vaccinesVaccines > Application > Therapeutic vaccineVaccines > Development/production technology > Recombinant vector vaccine > Viral vector vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsCarcinoma, Non-Small-Cell LungStomach NeoplasmsColonic Neoplasms +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesAustralia
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesGritstone Bio Inc
China Registration ClassN/A

Develop Information

Active CompaniesGritstone Bio Inc
Inactive CompaniesN/A
Active IndicationsCarcinoma, Non-Small-Cell LungStomach NeoplasmsColorectal Neoplasms +[5] 
Inactive IndicationsColonic Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A